Diabetes 50:2013-2020, 2001
© 2001 by the American Diabetes Association, Inc.
Calpains Play a Role in Insulin Secretion and Action
Seamus K. Sreenan1,
Yun-Ping Zhou1,
Kenichi Otani1,8,
Polly A. Hansen6,
Kevin P.M. Currie2,
Chien-Yuan Pan2,
Jean-Pyo Lee1,
Diane M. Ostrega1,
William Pugh1,
Yukio Horikawa3,5,
Nancy J. Cox1,4,
Craig L. Hanis7,
Charles F. Burant6,
Aaron P. Fox2,
Graeme I. Bell1,3,4,5, and
Kenneth S. Polonsky8
1 Medicine
2 Neurobiology, Pharmacology and Physiology
3 Biochemistry and Molecular Biology, and
4 Human Genetics, and the
5 Howard Hughes Medical Institute, the University of Chicago, Chicago, Illinois
6 Department of Cell Biology, Parke-Davis Pharmaceutical Research Division/Warner-Lambert Company, Ann Arbor, Michigan
7 Human Genetics Center, the University of Texas Health Science Center at Houston, Houston, Texas
8 Department of Medicine, Washington University, St. Louis, Missouri
Studies of the genetic basis of type 2 diabetes suggest that variation in the calpain-10 gene affects susceptibility to this common disorder, raising the possibility that calpain-sensitive pathways may play a role in regulating insulin secretion and/or action. Calpains are ubiquitously expressed cysteine proteases that are thought to regulate a variety of normal cellular functions. Here, we report that short-term (4-h) exposure to the cell-permeable calpain inhibitors calpain inhibitor II and E-64-d increases the insulin secretory response to glucose in mouse pancreatic islets. This dose-dependent effect is observed at glucose concentrations above 8 mmol/l. This effect was also seen with other calpain inhibitors with different mechanisms of action but not with cathepsin inhibitors or other protease inhibitors. Enhancement of insulin secretion with short-term exposure to calpain inhibitors is not mediated by increased responses in intracellular Ca2+ or increased glucose metabolism in islets but by accelerated exocytosis of insulin granules. In muscle strips and adipocytes, exposure to both calpain inhibitor II and E-64-d reduced insulin-mediated glucose transport. Incorporation of glucose into glycogen in muscle also was reduced. These results are consistent with a role for calpains in the regulation of insulin secretion and insulin action.

CiteULike Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
M. Meier, H. H Klein, J. Kramer, M. Drenckhan, and M. Schutt
Calpain inhibition impairs glycogen syntheses in HepG2 hepatoma cells without altering insulin signaling
J. Endocrinol.,
April 1, 2007;
193(1):
45 - 51.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Vollmert, S. Hahn, C. Lamina, C. Huth, M. Kolz, A. Schopfer-Wendels, K. Mann, F. Bongardt, J. C. Mueller, F. Kronenberg, et al.
Calpain-10 variants and haplotypes are associated with polycystic ovary syndrome in Caucasians
Am J Physiol Endocrinol Metab,
March 1, 2007;
292(3):
E836 - E844.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. Yajima, M. Sato, H. Sorimachi, M. Inomata, M. Maki, and S. Kawashima
Calpain System Regulates the Differentiation of Adult Primitive Mesenchymal ST-13 Adipocytes
Endocrinology,
October 1, 2006;
147(10):
4811 - 4819.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. Otani, K. S. Polonsky, J. O. Holloszy, and D.-H. Han
Inhibition of calpain results in impaired contraction-stimulated GLUT4 translocation in skeletal muscle
Am J Physiol Endocrinol Metab,
September 1, 2006;
291(3):
E544 - E548.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. D. Lopez-Avalos, V. F. Duvivier-Kali, G. Xu, S. Bonner-Weir, A. Sharma, and G. C. Weir
Evidence for a role of the ubiquitin-proteasome pathway in pancreatic islets.
Diabetes,
May 1, 2006;
55(5):
1223 - 1231.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. Lu, T. Ventura-Holman, J. Li, R. W. McMurray, J. S. Subauste, and J. F. Maher
Abnormal Glucose Homeostasis and Pancreatic Islet Function in Mice with Inactivation of the Fem1b Gene
Mol. Cell. Biol.,
August 1, 2005;
25(15):
6570 - 6577.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. Parnaud, E. Hammar, D. G. Rouiller, and D. Bosco
Inhibition of calpain blocks pancreatic {beta}-cell spreading and insulin secretion
Am J Physiol Endocrinol Metab,
August 1, 2005;
289(2):
E313 - E321.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. H. Suh, Y. Kim, J. H. Bang, K. S. Choi, J. W. Lee, W.-H. Kim, T. J. Oh, S. An, and M. H. Jung
Analysis of gene expression profiles in insulin-sensitive tissues from pre-diabetic and diabetic Zucker diabetic fatty rats
J. Mol. Endocrinol.,
April 1, 2005;
34(2):
299 - 315.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. F. Escobar-Morreale, M. Luque-Ramirez, and J. L. San Millan
The Molecular-Genetic Basis of Functional Hyperandrogenism and the Polycystic Ovary Syndrome
Endocr. Rev.,
April 1, 2005;
26(2):
251 - 282.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. O. Goodarzi, K. D. Taylor, X. Guo, M. J. Quinones, J. Cui, Y. Li, M. F. Saad, H. Yang, W. A. Hsueh, H. N. Hodis, et al.
Association of the Diabetes Gene Calpain-10 With Subclinical Atherosclerosis: The Mexican-American Coronary Artery Disease Study
Diabetes,
April 1, 2005;
54(4):
1228 - 1232.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Marshall, G. A. Hitman, C. J. Partridge, A. Clark, H. Ma, T. R. Shearer, and M. D. Turner
Evidence that an Isoform of Calpain-10 Is a Regulator of Exocytosis in Pancreatic {beta}-Cells
Mol. Endocrinol.,
January 1, 2005;
19(1):
213 - 224.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. Carlsson, J. Fredriksson, L. Groop, and M. Ridderstrale
Variation in the Calpain-10 Gene Is Associated with Elevated Triglyceride Levels and Reduced Adipose Tissue Messenger Ribonucleic Acid Expression in Obese Swedish Subjects
J. Clin. Endocrinol. Metab.,
July 1, 2004;
89(7):
3601 - 3605.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. D. Johnson, Z. Han, K. Otani, H. Ye, Y. Zhang, H. Wu, Y. Horikawa, S. Misler, G. I. Bell, and K. S. Polonsky
RyR2 and Calpain-10 Delineate a Novel Apoptosis Pathway in Pancreatic Islets
J. Biol. Chem.,
June 4, 2004;
279(23):
24794 - 24802.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. Otani, D.-H. Han, E. L. Ford, P. M. Garcia-Roves, H. Ye, Y. Horikawa, G. I. Bell, J. O. Holloszy, and K. S. Polonsky
Calpain System Regulates Muscle Mass and Glucose Transporter GLUT4 Turnover
J. Biol. Chem.,
May 14, 2004;
279(20):
20915 - 20920.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. Suzuki, S. Hata, Y. Kawabata, and H. Sorimachi
Structure, Activation, and Biology of Calpain
Diabetes,
February 1, 2004;
53(90001):
S12 - 18.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
N. J. Cox, M. G. Hayes, C. A. Roe, T. Tsuchiya, and G. I. Bell
Linkage of Calpain 10 to Type 2 Diabetes: The Biological Rationale
Diabetes,
February 1, 2004;
53(90001):
S19 - 25.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
S. K. Rasmussen, S. A. Urhammer, L. Berglund, J. N. Jensen, L. Hansen, S. M. Echwald, K. Borch-Johnsen, Y. Horikawa, H. Mashima, H. Lithell, et al.
Variants Within the Calpain-10 Gene on Chromosome 2q37 (NIDDM1) and Relationships to Type 2 Diabetes, Insulin Resistance, and Impaired Acute Insulin Secretion Among Scandinavian Caucasians
Diabetes,
December 1, 2002;
51(12):
3561 - 3567.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. J. Smith and A. J. Lusis
The allelic structure of common disease
Hum. Mol. Genet.,
October 1, 2002;
11(20):
2455 - 2461.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. W. Rutledge and S. W. Whiteheart
SNAP-23 Is a Target for Calpain Cleavage in Activated Platelets
J. Biol. Chem.,
September 27, 2002;
277(40):
37009 - 37015.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. F. White
IRS proteins and the common path to diabetes
Am J Physiol Endocrinol Metab,
September 1, 2002;
283(3):
E413 - E422.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. G. Cassell, A. E. Jackson, B. V. North, J. C. Evans, D. Syndercombe-Court, C. Phillips, A. Ramachandran, C. Snehalatha, S. V. Gelding, S. Vijayaravaghan, et al.
Haplotype Combinations of Calpain 10 Gene Polymorphisms Associate With Increased Risk of Impaired Glucose Tolerance and Type 2 Diabetes in South Indians
Diabetes,
May 1, 2002;
51(5):
1622 - 1628.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. C. Elbein, W. Chu, Q. Ren, C. Hemphill, J. Schay, N. J. Cox, C. L. Hanis, and S. J. Hasstedt
Role of Calpain-10 Gene Variants in Familial Type 2 Diabetes in Caucasians
J. Clin. Endocrinol. Metab.,
February 1, 2002;
87(2):
650 - 654.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. J. Cox
Challenges in identifying genetic variation affecting susceptibility to type 2 diabetes: examples from studies of the calpain-10 gene
Hum. Mol. Genet.,
October 1, 2001;
10(20):
2301 - 2305.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2001 by the American Diabetes Association.
|
|
| |
|